Completed PHASE4 INTERVENTIONAL 1-arm NCT00943969

Determinants of Oral Morphine Answer Among Obese Patients Before and After Gastric Bypass (OBEMO)

Sponsor: Hopital Lariboisière

Conditions Obesity

Updated 7 times since 2017 Last updated: Dec 14, 2015 Started: Apr 30, 2009 Primary completion: May 31, 2009 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obesity, this trial is completed. The trial is conducted by Hopital Lariboisière and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital Lariboisière

Data source: Hopital Lariboisière

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France